Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

A guide to cell death pathways
Junying Yuan, Dimitry Ofengeim
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 5, pp. 379-395
Closed Access | Times Cited: 291
The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms
Ming‐Chang Chiang, Tsung‐Yu Tsai, Chieh-Ju Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6328-6328
Open Access | Times Cited: 84
DAMPs and DAMP-sensing receptors in inflammation and diseases
Ming Ma, Wei Jiang, Rongbin Zhou
Immunity (2024) Vol. 57, Iss. 4, pp. 752-771
Open Access | Times Cited: 71
Luteolin enhanced antioxidant capability and induced pyroptosis through NF-κB/NLRP3/Caspase-1 in splenic lymphocytes exposure to ammonia
Dechun Chen, F Shen, Jiahao Liu, et al.
The Science of The Total Environment (2024) Vol. 919, pp. 170699-170699
Closed Access | Times Cited: 24
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Sara Cicchinelli, Giulia Pignataro, Stefania Gemma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 962-962
Open Access | Times Cited: 22
“The NET effect”: Neutrophil extracellular traps—a potential key component of the dysregulated host immune response in sepsis
Andrew Retter, Mervyn Singer, Djillali Annane
Critical Care (2025) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Activation and evasion of inflammasomes during viral and microbial infection
Dan Ren, Xiaoou Ye, Ruimin Chen, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 2
Signal-induced NLRP3 phase separation initiates inflammasome activation
Guijin Zou, Young Tang, Jie Yang, et al.
Cell Research (2025)
Open Access | Times Cited: 2
Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies
Wen‐Jun Li, Jinze Wu, Yini Zeng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
Pasquale Pagliaro, Cláudia Penna
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1396-1396
Open Access | Times Cited: 26
Brazilin is a natural product inhibitor of the NLRP3 inflammasome
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108968-108968
Open Access | Times Cited: 8
New aspects of redox signaling mediated by supersulfides in health and disease
Takaaki Akaike, Masanobu Morita, Seiryo Ogata, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 539-551
Open Access | Times Cited: 8
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca
Vascular Pharmacology (2025), pp. 107462-107462
Closed Access | Times Cited: 1
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 18
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 17
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 7
Circulating perturbation of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) is associated to cardiac remodeling and NLRP3 inflammasome in cardiovascular patients with insulin resistance risk
Elena Vianello, Federico Ambrogi, Marta Kalousová, et al.
Experimental and Molecular Pathology (2024) Vol. 137, pp. 104895-104895
Open Access | Times Cited: 6
The NLRP3 inflammasome in allergic diseases: mechanisms and therapeutic implications
Huiqin Zhou, Li Wang, Wei Lv, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
Xin Sun, Le Yang, Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Microglia NLRP3 Inflammasome and Neuroimmune Signaling in Substance Use Disorders
Ming‐Lei Guo, Soheil Kazemi Roodsari, Yan Cheng, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 922-922
Open Access | Times Cited: 14
Anti-inflammatory and uric acid lowering effects of Euodiae fructus on hyperuricemia and gout mice
Zhilei Wang, Jingwen Liu, Yu Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies
Hui-Fei Lu, Yi-Chi Zhou, Tianyong Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors
Ye Tian, Xiaofang He, Ruping Li, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117874-117874
Closed Access | Times Cited: 5
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
Miguel Á. Ortega, Diego De León-Oliva, Cielo García‐Montero, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening
George D. Hartman, Paul S. Humphries, Robert Hughes, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 102, pp. 129675-129675
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top